In "Master of Death", he exposed illegal military expeditions to Mexico and Colombia while "The Blind Spot" helped reopen the investigations into the Oktoberfest terror attack in 1980.
"There are certain places where if you expose important people, your life is in danger. In Germany, we can do it without fearing for our lives. So, I feel it is our obligation to do that kind of reporting work," Daniel told PTI.
"There are some people who may not like our work, but we have to do it. We believe in our work and the stories we have to tell. It is an important pillar of democracy," he adds.
"We are not looking at India being the victim of fake drugs. It's about the German market. Part of the setting is India which has helped us tell our story," Daniel says.
The film is an amalgamation of facts and fiction. It is based on extensive research by Daniel and his team.
According to the filmmaker, it was during their research when they came across counterfeit drugs for the first time and made a 90-min documentary, "exposing the scale of such pharmaceutical companies rolling out fake drugs."
"It all started with a documentary project on thalidomide, a medicine made by a German company, a sleeping medicine, that ended up severely affecting pregnant women and resulted in thousands of dead and disabled children all over the world," he says.
The film, starring German stars like Heiner Lauterbach, Julia Koschitz, Luise Heyer and Bollywood actor Arfi Lamba, was shot in some of the slum areas of Mumbai.
Daniel says despite some minor hurdles, it was an "easy" shoot and he felt safe here as compared to Mexico, where he has previously shot for his films.
"I did have some issues with the shoot. In Europe, if you're shooting, people try to cut prices to make you comfortable. But the moment our unions see a foreign crew, they double the price. It's discouraging when people are trying to bring jobs here."
The film is set to release on May 15 in Germany, Switzerland and Austria.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
